Clinical Trans Valid: The Center for Advancing Point of Care Technologies in Heart, Lung, Blood and Sleep Diseases

Clinical Trans Valid：心脏、肺、血液和睡眠疾病护理点技术推进中心

• 批准号: 10222764
• 负责人: David D. McManus
• 金额: $ 17.26万
• 依托单位: UNIV OF MASSACHUSETTS MED SCH WORCESTER
• 依托单位国家: 美国
• 财政年份: 2018
• 资助国家: 美国
• 起止时间: 2018-08-22 至 2023-07-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10222764
• 关键词: Adoption; American; Caregivers; Caring; Chronic Disease; Clinical; Clinical Research; Development; Devices; Diagnosis; Epidemiology; Feedback; Funding; Goals; Health; Healthcare; Heart Diseases; Hematological Disease; Individual; Informatics; Investments; Learning; Lung diseases; Mobile Health Application; Outpatients; Participant; Patient Recruitments; Patients; Pilot Projects; Point of Care Technology; Preventive measure; Provider; Research; Research Design; Research Support; Resources; Science; Services; Sleep Disorders; Technology; Testing; Time; Translations; Validation; Work; acute care; clinical care; clinical translation; commercialization; data integration; data tools; design; ethnic diversity; improved; industry partner; multidisciplinary; novel; patient oriented; point of care; point of care testing; precision medicine; prototype; research clinical testing; tool; trial design; usability

PROJECT SUMMARY/ABSTRACT – CLINICAL TRANSLATION AND VALIDATION CORE American healthcare is rapidly evolving to a state where efficiency and quality in health care are co-dominant drivers. Point-of-care technologies (POCT) are an important tool for providers and patients to receive immediate feedback on critical health issues. In acute care settings, caregivers need real-time POCT to guide treatment in rapidly changing circumstances; and in the outpatient setting providers are seeking ways to engage patients with preventative measures and implement precision medicine. The goal of CAPCaT is to develop and optimize novel POCT to improve the diagnosis and management of heart, lung, blood and sleep (HLBS) diseases. The Clinical Translation and Validation (CTV) core will be responsible for validating the prototypes and establishing the feasibility of adoption of these devices in settings appropriate to the specific technology being tested. Therefore, we will maintain a broad array of services necessary to facilitate clinical research, and support the specific needs of individual projects.

项目总结/摘要-临床翻译和验证核心 美国的医疗保健正在迅速发展到一个国家，在那里的效率和质量的医疗保健是 共同主导的驱动程序。护理点技术（POCT）是提供者的重要工具， 患者在关键健康问题上获得即时反馈。在急性护理环境中，护理人员 需要实时POCT在快速变化的情况下指导治疗; 设置提供者正在寻找方法，使患者参与预防措施，并实施 精准医疗CAPCaT的目标是开发和优化新型POCT，以改善 心、肺、血液和睡眠（HLBS）疾病的诊断和管理。临床 翻译和验证（CTV）核心将负责验证原型， 确定在适合特定环境中采用这些器械的可行性， 正在测试的技术。因此，我们将继续提供各种必要的服务， 促进临床研究，并支持个别项目的具体需求。